Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.050
-0.110 (-3.48%)
Jun 20, 2025, 11:47 AM - Market open
IMDX Employees
As of December 31, 2024, Insight Molecular Diagnostics Inc. had 49 total employees, including 46 full-time and 3 part-time employees. The number of employees increased by 3 or 6.52% compared to the previous year.
Employees
49
Change (1Y)
3
Growth (1Y)
6.52%
Revenue / Employee
$78,429
Profits / Employee
-$1,189,020
Market Cap
87.23M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
IMDX News
- 3 days ago - Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville - GlobeNewsWire
- 4 weeks ago - Medicare Boosts Reimbursement for Oncocyte's Flagship Technology - GlobeNewsWire
- 5 weeks ago - OncoCyte Corporation (OCX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Oncocyte Reports Q1 2025 Results and Business Progress - GlobeNewsWire
- 6 weeks ago - Oncocyte to Release First Quarter 2025 Results on May 12, 2025 - GlobeNewsWire
- 7 weeks ago - Oncocyte Provides Positive Update on Clinical Trial Progress - GlobeNewsWire
- 7 weeks ago - Oncocyte's Proprietary Assay Demonstrates Long-Term Clinical Validity - GlobeNewsWire
- 3 months ago - OncoCyte Corporation (OCX) Q4 2024 Earnings Call Transcript - Seeking Alpha